export interface BlogPost {
  slug: string;
  title: string;
  excerpt: string;
  content: string[];
  pillar: string;
  pillarSlug: string;
  author: {
    name: string;
    role: string;
    avatar: string;
  };
  date: string;
  readTime: string;
  featured: boolean;
  tags: string[];
  relatedSlugs: string[];
}

// 5 SEO content pillars mapped to product category accent colors
export const blogPillars = [
  {
    name: "All",
    slug: "all",
    color: "",
    count: 0, // filled dynamically below
  },
  {
    name: "SARMs Research",
    slug: "sarms-research",
    color: "#FF6B6B",
    glow: "rgba(160,3,3,0.45)",
    description: "Guides, comparisons, and research overviews for selective androgen receptor modulators.",
  },
  {
    name: "Peptide Science",
    slug: "peptide-science",
    color: "#55b3ff",
    glow: "rgba(85,179,255,0.45)",
    description: "In-depth research on BPC-157, TB-500, GH peptides, and the broader peptide landscape.",
  },
  {
    name: "GLP-1 & Metabolic",
    slug: "glp1-metabolic",
    color: "#FFB347",
    glow: "rgba(255,179,71,0.45)",
    description: "Research on Retatrutide, Semaglutide, and next-generation metabolic compounds.",
  },
  {
    name: "Nootropics & Cognitive",
    slug: "nootropics-cognitive",
    color: "#a78bfa",
    glow: "rgba(167,139,250,0.45)",
    description: "The science of cognitive research compounds — racetams, cholinergics, and peptide nootropics.",
  },
  {
    name: "Research Protocols",
    slug: "research-protocols",
    color: "#5fc992",
    glow: "rgba(95,201,146,0.45)",
    description: "Lab best practices: reconstitution, storage, third-party testing, and regulatory guidance.",
  },
];

export const blogPosts: BlogPost[] = [
  // ─── SARMs Research ──────────────────────────────────────────────────────────
  {
    slug: "what-are-sarms-complete-guide",
    title: "What Are SARMs? A Complete Research Guide",
    excerpt:
      "Everything researchers need to know about Selective Androgen Receptor Modulators — how they work, what makes them useful in research, and the key compounds currently under investigation.",
    content: [
      "Selective Androgen Receptor Modulators (SARMs) are one of the most actively researched classes of compounds in modern pharmacology. Their defining characteristic — the ability to selectively bind androgen receptors in specific tissue types — makes them uniquely valuable tools for studying anabolic signaling pathways without the broad systemic effects of traditional androgens.",
      "## How SARMs Work",
      "SARMs bind to androgen receptors (AR) — the same receptors that respond to testosterone and dihydrotestosterone (DHT). What makes SARMs distinct is tissue selectivity: they preferentially activate ARs in muscle and bone tissue while exhibiting reduced activity in tissues like the prostate and sebaceous glands. This selectivity is achieved through conformational changes in the receptor that produce different downstream transcription patterns depending on which co-activator proteins are recruited in a given tissue.",
      "This mechanism is fundamentally different from anabolic steroids, which activate androgen receptors non-selectively throughout the body, producing both desired anabolic effects and a full profile of androgenic side effects.",
      "## Key SARMs Currently Under Investigation",
      "RAD-140 (Testolone) demonstrates among the highest binding affinity of any SARM studied to date, with a notably high anabolic-to-androgenic ratio in preclinical models. It is a full agonist in muscle and bone tissue and has attracted attention in neuroprotection research. LGD-4033 (Ligandrol) is one of the most clinically studied SARMs, with Phase I and Phase II trials establishing its pharmacokinetic profile, dose-response relationship, and safety parameters. MK-677 (Ibutamoren), while technically a ghrelin receptor agonist rather than a SARM, is frequently studied alongside SARMs for its GH secretagogue properties. S-4 (Andarine) is a foundational partial agonist used in tissue-selectivity studies to understand differential receptor activation.",
      "## Why SARMs Are Useful in Research",
      "The tissue-selective mechanism makes SARMs powerful research tools for several applications: studying androgen receptor biology without confounding systemic androgenic effects, investigating anabolic signaling in muscle wasting disease models, exploring bone density and osteoporosis mechanisms, and understanding hormonal dysregulation pathways.",
      "The ability to isolate receptor activity in specific tissue types allows researchers to dissect biological mechanisms that would be impossible to study cleanly with non-selective androgens.",
      "## Purity and Verification",
      "Because SARMs research depends on precise receptor binding data, compound purity is non-negotiable. Even small impurities can alter dose-response curves and produce misleading results. Independent HPLC and mass spectrometry verification are the minimum acceptable standard for research-grade SARMs. All PureRawz SARMs ship with third-party COA documentation confirming identity and purity.",
      "## Conclusion",
      "SARMs represent a scientifically fascinating class of compounds that continue to generate significant research interest. Their selectivity for androgen receptors in specific tissues makes them indispensable tools for understanding anabolic biology. As research continues, the pharmacological profile of each SARM compound becomes better characterized, enabling increasingly sophisticated experimental protocols.",
    ],
    pillar: "SARMs Research",
    pillarSlug: "sarms-research",
    author: {
      name: "Dr. Sarah Chen",
      role: "Research Director",
      avatar: "SC",
    },
    date: "2025-03-20",
    readTime: "11 min read",
    featured: true,
    tags: ["SARMs", "Research", "Androgen Receptors", "RAD-140", "LGD-4033"],
    relatedSlugs: ["rad-140-vs-lgd-4033", "complete-guide-to-sarms-research"],
  },
  {
    slug: "rad-140-vs-lgd-4033",
    title: "RAD-140 vs LGD-4033: Comparing Two Leading SARMs",
    excerpt:
      "A head-to-head comparison of RAD-140 (Testolone) and LGD-4033 (Ligandrol) — binding affinity, tissue selectivity, pharmacokinetics, and how each fits into different research protocols.",
    content: [
      "RAD-140 and LGD-4033 are consistently among the most studied SARMs in published research. While both are full agonists at the androgen receptor in muscle and bone tissue, they have meaningfully different pharmacological profiles. Understanding these differences is critical for selecting the right compound for a given experimental design.",
      "## Binding Affinity and Selectivity",
      "RAD-140 demonstrates an exceptionally high binding affinity for the androgen receptor, with some studies reporting Ki values in the low nanomolar range — comparable to or exceeding testosterone itself. Its tissue selectivity index is among the highest of any SARM studied, meaning its ratio of anabolic to androgenic activity is particularly favorable for studying muscle and bone pathways in isolation. LGD-4033 also exhibits high AR affinity and strong anabolic activity, but with a somewhat broader tissue activity profile. Its selectivity is well-characterized across multiple clinical studies, making it the SARM with the most robust human pharmacokinetic data available.",
      "## Pharmacokinetics",
      "LGD-4033 has a half-life of approximately 24–36 hours in human pharmacokinetic studies, enabling once-daily dosing in research protocols. Bioavailability is high. RAD-140 has a shorter half-life of roughly 15–20 hours in preclinical models. It is highly lipophilic, which affects its tissue distribution kinetics. Both compounds are orally bioavailable, making them practical for research protocols that require systemic administration without injection.",
      "## Research Applications",
      "LGD-4033 is the preferred choice when research protocols require well-characterized pharmacokinetics and dose-response data from existing clinical literature. It is the SARM with the most human study data, including Phase II trials examining lean mass, physical function, and safety. RAD-140 is the preferred compound when high binding affinity and high tissue selectivity are the primary experimental requirements. It is also increasingly used in neuroprotection research following publications suggesting activity in neural tissue — a property not well-documented for LGD-4033.",
      "## Key Differences Summary",
      "RAD-140 offers higher reported binding affinity and a higher anabolic-to-androgenic selectivity index. LGD-4033 offers more extensive published human pharmacokinetic data and a longer half-life suitable for simplified dosing protocols. For pure muscle anabolic signaling studies, either compound is appropriate. For selectivity-focused research or neuroprotection studies, RAD-140 is the stronger choice. For protocols requiring established human PK data as a reference, LGD-4033 is preferred.",
      "## Conclusion",
      "Both RAD-140 and LGD-4033 are excellent research tools, and the choice between them should be driven by the specific experimental objectives. Understanding their pharmacological differences enables researchers to design more precise and reproducible protocols. PureRawz stocks both compounds at 99%+ purity with full COA documentation.",
    ],
    pillar: "SARMs Research",
    pillarSlug: "sarms-research",
    author: {
      name: "Dr. Marcus Rivera",
      role: "Lead Pharmacologist",
      avatar: "MR",
    },
    date: "2025-03-18",
    readTime: "9 min read",
    featured: false,
    tags: ["RAD-140", "LGD-4033", "SARMs", "Comparison", "Pharmacology"],
    relatedSlugs: ["what-are-sarms-complete-guide", "complete-guide-to-sarms-research"],
  },
  {
    slug: "complete-guide-to-sarms-research",
    title: "The Complete Guide to SARMs Research in 2025",
    excerpt:
      "An in-depth look at the current state of Selective Androgen Receptor Modulator research, methodologies, and best practices for laboratory protocols.",
    content: [
      "Selective Androgen Receptor Modulators (SARMs) have become one of the most actively studied classes of compounds in modern pharmacological research. Their unique mechanism of selectively binding to androgen receptors in specific tissues has made them subjects of intense scientific interest.",
      "## Understanding SARMs Mechanism of Action",
      "SARMs work by selectively targeting androgen receptors in muscle and bone tissue, unlike traditional anabolic agents that affect receptors throughout the body. This tissue selectivity is what makes them so compelling for research applications, as it opens the door to understanding targeted receptor modulation without the broad systemic effects seen with less selective compounds.",
      "The key classes of SARMs currently under investigation include Ostarine (MK-2866), RAD-140 (Testolone), LGD-4033 (Ligandrol), and S-4 (Andarine). Each exhibits a distinct binding affinity profile and tissue selectivity pattern that researchers can leverage for specific experimental protocols.",
      "## Laboratory Best Practices",
      "When conducting SARMs research, maintaining rigorous laboratory standards is paramount. This includes proper storage conditions (typically cool, dry environments away from direct light), precise measurement using calibrated instruments, and detailed documentation of all experimental parameters.",
      "Researchers should always verify compound identity and purity through independent testing. At PureRawz, every batch ships with a Certificate of Authenticity (COA) documenting third-party analytical testing results, including HPLC purity analysis and mass spectrometry confirmation.",
      "## Dosing Protocols in Research",
      "Establishing appropriate dosing protocols is critical for reproducible results. Research literature suggests that dose-response curves for SARMs tend to follow a sigmoidal pattern, with a plateau effect at higher concentrations.",
      "For in-vitro studies, concentration ranges typically span from nanomolar to low micromolar levels. For in-vivo animal model studies, published protocols generally use doses ranging from 0.1 to 10 mg/kg body weight, depending on the specific compound and research objective.",
      "## Current Research Frontiers",
      "The most exciting areas of SARMs research in 2025 include investigations into muscle wasting conditions, osteoporosis models, and hormonal dysregulation. Several compounds are in various stages of clinical investigation, with results expected to significantly advance our understanding of selective receptor modulation.",
      "## Conclusion",
      "SARMs research continues to expand at a rapid pace, driven by the promise of tissue-selective androgen receptor modulation. By maintaining rigorous laboratory standards, using verified compounds, and following established protocols, researchers can contribute meaningful data to this important field of study.",
    ],
    pillar: "SARMs Research",
    pillarSlug: "sarms-research",
    author: {
      name: "Dr. Sarah Chen",
      role: "Research Director",
      avatar: "SC",
    },
    date: "2025-03-15",
    readTime: "12 min read",
    featured: false,
    tags: ["SARMs", "Research", "Laboratory", "Protocols"],
    relatedSlugs: ["rad-140-vs-lgd-4033", "what-are-sarms-complete-guide"],
  },
  {
    slug: "understanding-rad-140-research",
    title: "Understanding RAD-140 (Testolone): A Research Overview",
    excerpt:
      "Exploring the pharmacological profile of RAD-140, one of the most studied SARMs in current research, including binding affinity data and published findings.",
    content: [
      "RAD-140, also known as Testolone, has emerged as one of the most researched Selective Androgen Receptor Modulators in the scientific community. Developed initially by Radius Health Inc., this compound has attracted significant attention due to its high binding affinity and tissue selectivity.",
      "## Pharmacological Profile",
      "RAD-140 demonstrates a notably high binding affinity for the androgen receptor (AR), with studies reporting an IC50 value in the low nanomolar range. What distinguishes RAD-140 from other SARMs is its particularly high selectivity index — the ratio between its anabolic activity in target tissues versus its androgenic activity in non-target tissues.",
      "## Key Research Findings",
      "Published research on RAD-140 spans several important domains. Muscle tissue studies have demonstrated dose-dependent increases in lean mass in animal models. Bone density research has shown promising results in osteoporosis models. Neuroprotective research has indicated that RAD-140 may have effects on neural tissue, though this area remains in early-stage investigation.",
      "## Storage and Handling",
      "For optimal research results, RAD-140 should be stored at room temperature (20-25°C) in a cool, dry place away from direct sunlight. Solutions should be prepared fresh when possible, and reconstituted materials stored at 4°C.",
      "## Analytical Verification",
      "Given the importance of compound purity in research, RAD-140 should be verified via HPLC analysis before use in any experimental protocol. PureRawz provides COA documentation with every batch.",
      "## Future Directions",
      "Ongoing research into RAD-140 continues to explore its receptor binding kinetics, metabolic pathways, and potential applications across multiple therapeutic areas.",
    ],
    pillar: "SARMs Research",
    pillarSlug: "sarms-research",
    author: {
      name: "Dr. Marcus Rivera",
      role: "Lead Pharmacologist",
      avatar: "MR",
    },
    date: "2025-03-10",
    readTime: "9 min read",
    featured: false,
    tags: ["RAD-140", "Testolone", "Pharmacology", "SARMs"],
    relatedSlugs: ["what-are-sarms-complete-guide", "rad-140-vs-lgd-4033"],
  },

  // ─── Peptide Science ──────────────────────────────────────────────────────────
  {
    slug: "bpc-157-vs-tb-500",
    title: "BPC-157 vs TB-500: Research Comparison Guide",
    excerpt:
      "A detailed comparison of two of the most studied research peptides — BPC-157 and TB-500 — covering mechanisms, tissue targets, published findings, and how each fits into repair and regeneration research.",
    content: [
      "BPC-157 and TB-500 are the two most widely studied research peptides in the area of tissue repair and regeneration. They are frequently compared — and often studied together — but they have meaningfully different mechanisms and research profiles. Understanding the distinction is essential for designing appropriate experimental protocols.",
      "## BPC-157: The Gastric Peptide",
      "BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide (15 amino acids) derived from a partial sequence of a naturally occurring gastric protein. It exhibits remarkable stability in gastric acid — unusual for a peptide — and has been studied across a broad range of tissue types including tendon, ligament, muscle, bone, and gastrointestinal epithelium.",
      "The primary proposed mechanism involves upregulation of growth factor signaling, particularly VEGF (Vascular Endothelial Growth Factor) and the nitric oxide system, promoting angiogenesis in healing tissue. Published research spans cytoprotective studies in gastric models, tendon healing research, and CNS studies examining dopaminergic and serotonergic modulation.",
      "## TB-500: The Thymosin Beta-4 Analog",
      "TB-500 is a synthetic analog of Thymosin Beta-4 (Tβ4), a naturally occurring peptide present in virtually all human cells. Its central mechanism involves actin sequestration — TB-500 binds G-actin monomers, which regulates cytoskeletal dynamics and is fundamental to cell migration and tissue repair processes.",
      "The actin-sequestration mechanism gives TB-500 a distinctly different research profile from BPC-157. Where BPC-157 research tends to focus on growth factor upregulation, TB-500 research focuses on cellular motility, actin polymerization, and the regulation of angiogenesis and inflammation through different downstream pathways.",
      "## Side-by-Side Comparison",
      "BPC-157 offers a broader body of published research with faster-developing evidence in specific tissue models. TB-500 has a well-characterized primary mechanism (actin binding) that is more directly linked to cellular migration dynamics. BPC-157 is extensively studied in GI and tendon models. TB-500 shows stronger evidence in cardiac and bone healing models. Both peptides are studied for angiogenic effects but through different molecular pathways. Both have attracted interest in combination protocols, with the BPC-157/TB-500 blend now a commonly studied stack in tissue repair research.",
      "## Combination Research",
      "The BPC-157/TB-500 blend has become a subject of its own research interest because the two compounds operate through complementary mechanisms. BPC-157's growth factor upregulation combined with TB-500's cellular migration facilitation may produce synergistic effects in tissue repair models. This is an area of active research with growing published literature.",
      "## Conclusion",
      "BPC-157 and TB-500 are complementary rather than competing research tools. BPC-157 is the stronger choice when studying growth factor-mediated repair and cytoprotective mechanisms. TB-500 is preferred when the research focus is on actin-dependent cell migration, cytoskeletal dynamics, and cardiac or bone tissue models. Many protocols incorporate both.",
    ],
    pillar: "Peptide Science",
    pillarSlug: "peptide-science",
    author: {
      name: "Dr. Elena Kowalski",
      role: "Peptide Research Specialist",
      avatar: "EK",
    },
    date: "2025-03-22",
    readTime: "10 min read",
    featured: false,
    tags: ["BPC-157", "TB-500", "Peptides", "Comparison", "Tissue Repair"],
    relatedSlugs: ["bpc-157-research-review", "mk-677-vs-ipamorelin"],
  },
  {
    slug: "mk-677-vs-ipamorelin",
    title: "MK-677 vs Ipamorelin: Comparing GH Secretagogues",
    excerpt:
      "A research-focused comparison of MK-677 (Ibutamoren) and Ipamorelin — two growth hormone secretagogues with different receptor mechanisms, half-lives, and experimental applications.",
    content: [
      "MK-677 and Ipamorelin are both growth hormone secretagogues, meaning they stimulate the release of endogenous growth hormone from the pituitary gland. However, they do so through different receptor systems, have different pharmacokinetic profiles, and produce meaningfully different GH pulse patterns. Selecting between them — or combining them — requires understanding these distinctions.",
      "## Mechanism of Action",
      "MK-677 is a ghrelin receptor (GHSR) agonist. It mimics ghrelin — the hunger hormone — binding to GHSRs in the pituitary and hypothalamus to stimulate GH release. Notably, it is orally bioavailable, which is highly unusual for compounds that act on the GH axis. Ipamorelin is a synthetic pentapeptide that also acts on GHSR, but is selective for the pituitary isoform of the receptor. This selectivity is important: Ipamorelin produces GH release with minimal effect on cortisol, prolactin, or ACTH — making it one of the cleanest GH secretagogues in the research literature.",
      "## Pharmacokinetics",
      "MK-677 has a half-life of approximately 24 hours in human pharmacokinetic studies, enabling once-daily dosing and sustained GH elevation. It produces a GH pulse followed by elevated IGF-1 that persists throughout the day. Ipamorelin has a much shorter half-life of approximately 2 hours. It produces a sharp, discrete GH pulse shortly after administration, mimicking the body's natural pulsatile GH secretion pattern more closely than MK-677.",
      "## Research Applications",
      "MK-677 is preferred for protocols requiring sustained GH elevation and oral administration convenience. It is also the compound of choice for sleep architecture studies, given its 24-hour half-life and documented effects on REM and deep sleep stages. Ipamorelin is preferred when researchers want to study discrete, pulsatile GH release without affecting other hormonal axes. It is frequently combined with CJC-1295 (a GHRH analog) to produce a synchronized GH pulse — the CJC-1295/Ipamorelin combination is one of the most commonly studied GH protocols in the research literature.",
      "## Combined Protocols",
      "MK-677 and Ipamorelin can be studied together. The combination produces both the acute GH pulse from Ipamorelin and the sustained GH/IGF-1 elevation from MK-677, which may be useful for protocols studying both acute signaling dynamics and chronic GH axis activity. Both are available from PureRawz at 99%+ purity with full COA documentation.",
      "## Conclusion",
      "MK-677 and Ipamorelin are not interchangeable — they represent different experimental tools for studying the GH axis. MK-677's oral bioavailability and sustained action make it ideal for chronic protocols. Ipamorelin's selectivity and pulsatile action make it ideal for acute GH signaling studies and combination protocols with GHRH analogs.",
    ],
    pillar: "Peptide Science",
    pillarSlug: "peptide-science",
    author: {
      name: "Dr. Elena Kowalski",
      role: "Peptide Research Specialist",
      avatar: "EK",
    },
    date: "2025-03-12",
    readTime: "9 min read",
    featured: false,
    tags: ["MK-677", "Ipamorelin", "Growth Hormone", "Peptides", "Comparison"],
    relatedSlugs: ["bpc-157-vs-tb-500", "mk-677-ibutamoren-research-update"],
  },
  {
    slug: "bpc-157-research-review",
    title: "BPC-157 Research: Current Findings and Experimental Approaches",
    excerpt:
      "A comprehensive review of published BPC-157 research, including tissue repair studies, gastric protection models, and emerging areas of investigation.",
    content: [
      "BPC-157, a pentadecapeptide (15 amino acids) derived from human gastric juice protein, has become one of the most actively researched peptides in recent years. Its remarkable stability and broad spectrum of observed effects in preclinical models have generated significant scientific interest.",
      "## Background and Discovery",
      "BPC-157 (Body Protection Compound-157) was identified through systematic research on gastric juice proteins. Unlike many synthetic peptides, BPC-157 is notable for its stability in gastric acid, which is unusual for peptide compounds and suggests unique structural properties that resist enzymatic degradation.",
      "## Tissue Repair Research",
      "The most extensively studied application of BPC-157 is in tissue repair models. Published research has demonstrated effects across multiple tissue types including tendon, ligament, muscle, and gastrointestinal epithelium. The proposed mechanism involves upregulation of growth factor expression, particularly VEGF and its receptor system.",
      "## Gastric Protection Studies",
      "Given its origin from gastric juice, BPC-157 has been extensively studied in gastric protection models. Research has shown cytoprotective effects against various gastric insults, including NSAID-induced damage, ethanol exposure, and stress-induced lesions in animal models.",
      "## Emerging Research Areas",
      "Recent studies have expanded BPC-157 research into peripheral nerve regeneration, bone healing, and cardiovascular models. While these areas are still in early stages, the breadth of tissues showing responses to BPC-157 suggests a fundamental biological mechanism that warrants further investigation.",
      "## Experimental Considerations",
      "Researchers studying BPC-157 should be aware that dose ranges in published literature vary significantly, so establishing a dose-response curve in your specific model system is essential. Both systemic and local administration routes have been studied.",
      "## Conclusion",
      "BPC-157 represents a fascinating research peptide with an unusually broad spectrum of observed effects in preclinical models. As research continues to elucidate its mechanisms of action, this compound may offer important insights into fundamental tissue repair and protection processes.",
    ],
    pillar: "Peptide Science",
    pillarSlug: "peptide-science",
    author: {
      name: "Dr. Elena Kowalski",
      role: "Peptide Research Specialist",
      avatar: "EK",
    },
    date: "2025-02-20",
    readTime: "11 min read",
    featured: false,
    tags: ["BPC-157", "Peptides", "Tissue Repair", "Research"],
    relatedSlugs: ["bpc-157-vs-tb-500", "mk-677-vs-ipamorelin"],
  },
  {
    slug: "mk-677-ibutamoren-research-update",
    title: "MK-677 (Ibutamoren): Latest Research Developments",
    excerpt:
      "Reviewing recent publications on MK-677, a growth hormone secretagogue gaining attention in metabolic and sleep research.",
    content: [
      "MK-677, also known as Ibutamoren or Nutrobal, is a potent, non-peptide growth hormone secretagogue that has been the subject of increasing research interest. Unlike injectable growth hormone releasing peptides, MK-677 is orally active, making it particularly useful for certain research protocols.",
      "## Mechanism of Action",
      "MK-677 functions as a ghrelin receptor (GHSR) agonist, mimicking the action of the hunger hormone ghrelin. By activating the GHSR in the pituitary gland, it stimulates the release of growth hormone (GH) without significantly affecting cortisol levels — a notable distinction from other GH-stimulating approaches.",
      "## Metabolic Research",
      "Recent metabolic studies have focused on MK-677's effects on body composition parameters in animal models. Published data indicates effects on both lean mass accretion and fat oxidation, suggesting involvement in nutrient partitioning pathways.",
      "## Sleep Architecture Studies",
      "One of the more intriguing areas of MK-677 research involves its effects on sleep architecture. Studies have demonstrated increased duration of REM sleep and Stage 4 (deep) sleep in research subjects, potentially mediated through the ghrelin receptor's role in circadian rhythm regulation.",
      "## Bone Density Research",
      "Long-term administration studies in animal models have shown dose-dependent effects on bone mineral density markers, making MK-677 a subject of interest in osteoporosis research.",
      "## Conclusion",
      "MK-677 continues to prove its value as a research tool for studying GH signaling, metabolism, sleep architecture, and bone health. Its oral bioavailability and favorable pharmacokinetic profile make it uniquely suited for protocols that require sustained, physiological GH elevation.",
    ],
    pillar: "Peptide Science",
    pillarSlug: "peptide-science",
    author: {
      name: "Dr. Elena Kowalski",
      role: "Peptide Research Specialist",
      avatar: "EK",
    },
    date: "2025-02-05",
    readTime: "9 min read",
    featured: false,
    tags: ["MK-677", "Growth Hormone", "Metabolism", "Sleep"],
    relatedSlugs: ["mk-677-vs-ipamorelin", "bpc-157-vs-tb-500"],
  },

  // ─── GLP-1 & Metabolic ────────────────────────────────────────────────────────
  {
    slug: "what-is-retatrutide-glp1-research",
    title: "What Is Retatrutide? The Next GLP-1 Research Compound Explained",
    excerpt:
      "Retatrutide is the most-searched research peptide of 2025. Here's what makes it different from Semaglutide and Tirzepatide, how it works, and what the published research says so far.",
    content: [
      "Retatrutide (LY3437943) is a triple hormone receptor agonist developed by Eli Lilly that has generated extraordinary research interest. Unlike earlier GLP-1 receptor agonists, retatrutide simultaneously targets three receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple-agonist profile makes it pharmacologically distinct from both Semaglutide (GLP-1 only) and Tirzepatide (GLP-1 + GIP), and has produced striking results in Phase II clinical data.",
      "## The Triple Receptor Mechanism",
      "Understanding retatrutide's mechanism requires understanding what each receptor does. GLP-1 receptor activation reduces appetite, slows gastric emptying, and improves insulin secretion. GIP receptor activation works synergistically with GLP-1 on appetite and adds favorable effects on fat tissue and bone. Glucagon receptor activation — the key differentiator — increases energy expenditure through thermogenesis and enhances hepatic fat oxidation. The combination of appetite reduction (GLP-1 + GIP) with increased energy expenditure (glucagon) represents a mechanistically novel approach to metabolic research.",
      "## Phase II Research Data",
      "Published Phase II trial data showed dose-dependent body weight reductions over 48 weeks that exceeded those reported in comparable trials for Semaglutide and Tirzepatide at similar timepoints. The highest-dose group showed mean weight reductions of approximately 24% of baseline body weight — data that made retatrutide the most searched research compound of 2025 by a significant margin.",
      "## How It Differs From Semaglutide",
      "Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist only. Retatrutide adds GIP and glucagon agonism, producing additional metabolic effects that Semaglutide cannot. The glucagon component in particular drives increased energy expenditure that is absent with pure GLP-1 agonism.",
      "## How It Differs From Tirzepatide",
      "Tirzepatide (Mounjaro, Zepbound) is a GLP-1 and GIP dual agonist. Adding glucagon receptor agonism to these two is what makes retatrutide a triple agonist. The glucagon component has historically been challenging to include in metabolic compounds due to adverse glycemic effects, but retatrutide's design achieves glucagon receptor activation in a way that appears, in Phase II data, to be offset by GLP-1 and GIP-mediated insulin secretion.",
      "## Research Compound Availability",
      "PureRawz stocks research-grade retatrutide at 99%+ purity, COA-verified by independent HPLC and mass spectrometry. All purchases are for laboratory research purposes only.",
      "## Conclusion",
      "Retatrutide represents the leading edge of GLP-1 receptor agonist research. Its triple receptor mechanism differentiates it meaningfully from Semaglutide and Tirzepatide and has produced Phase II data that has driven enormous research interest. Researchers studying metabolic pathways, adipose tissue biology, or energy expenditure mechanisms will find retatrutide a uniquely powerful tool.",
    ],
    pillar: "GLP-1 & Metabolic",
    pillarSlug: "glp1-metabolic",
    author: {
      name: "Dr. Marcus Rivera",
      role: "Lead Pharmacologist",
      avatar: "MR",
    },
    date: "2025-03-25",
    readTime: "10 min read",
    featured: false,
    tags: ["Retatrutide", "GLP-1", "Metabolic Research", "Semaglutide", "Weight Loss"],
    relatedSlugs: ["semaglutide-vs-tirzepatide-research", "complete-guide-to-sarms-research"],
  },
  {
    slug: "semaglutide-vs-tirzepatide-research",
    title: "Semaglutide vs Tirzepatide: What the Research Actually Shows",
    excerpt:
      "A research-focused comparison of two GLP-1 receptor agonists at the center of metabolic medicine — how they differ mechanistically, what published trials reveal, and their distinct research applications.",
    content: [
      "Semaglutide and Tirzepatide are the two most-studied GLP-1-based compounds in clinical research, and the comparison between them has become one of the most searched topics in metabolic pharmacology. Understanding their mechanistic differences is essential for researchers selecting compounds for metabolic, adipose tissue, or endocrine research protocols.",
      "## The Fundamental Difference: Mono vs. Dual Agonism",
      "Semaglutide is a selective GLP-1 receptor agonist — it binds and activates the GLP-1 receptor (GLP-1R) only. Its effects on appetite, gastric emptying, insulin secretion, and glucagon suppression all flow from this single receptor interaction. Tirzepatide is a dual GIP/GLP-1 receptor agonist — a single molecule that activates both the GLP-1 receptor and the GIP receptor (GIPR) simultaneously. This dual activity is not simply additive. Research indicates that GIP receptor activation modulates GLP-1 receptor signaling in adipose tissue and the brain, producing effects that neither agonist produces independently.",
      "## Published Clinical Data",
      "The SUSTAIN and STEP trials for Semaglutide established its efficacy profile. The STEP 1 trial (Semaglutide 2.4mg weekly) showed mean weight reductions of approximately 14.9% over 68 weeks. The SURPASS trials for Tirzepatide showed mean weight reductions of 20-22% at the highest dose over 72 weeks. This comparison drove significant research interest in the dual agonism mechanism.",
      "## Mechanism-Specific Research Applications",
      "Semaglutide is the preferred reference compound when the specific research question involves GLP-1 receptor pharmacology. Its monoagonist profile produces clean GLP-1R-attributable data. Tirzepatide is the preferred compound when research involves GIP receptor biology, adipose tissue GIP signaling, or the interaction between GLP-1R and GIPR pathways. It is also the more appropriate compound when studying the additive effects of combined GLP-1 and GIP agonism on beta cell function.",
      "## Emerging Comparisons with Retatrutide",
      "The emerging triple agonist retatrutide adds glucagon receptor agonism to the GLP-1 + GIP profile of Tirzepatide, producing Phase II data that shows further metabolic effects. This three-way comparison — Semaglutide (mono), Tirzepatide (dual), Retatrutide (triple) — has become a key framework for understanding incremental receptor additions in metabolic research.",
      "## Conclusion",
      "Semaglutide and Tirzepatide are not simply 'better and worse' versions of the same compound — they are distinct pharmacological tools with different receptor profiles. Research protocol selection should be driven by which receptor mechanism is the specific subject of investigation.",
    ],
    pillar: "GLP-1 & Metabolic",
    pillarSlug: "glp1-metabolic",
    author: {
      name: "Dr. Sarah Chen",
      role: "Research Director",
      avatar: "SC",
    },
    date: "2025-03-08",
    readTime: "9 min read",
    featured: false,
    tags: ["Semaglutide", "Tirzepatide", "GLP-1", "Metabolic", "GIP"],
    relatedSlugs: ["what-is-retatrutide-glp1-research", "bpc-157-vs-tb-500"],
  },

  // ─── Nootropics & Cognitive ───────────────────────────────────────────────────
  {
    slug: "nootropics-research-landscape",
    title: "The Nootropics Research Landscape: 2025 Update",
    excerpt:
      "An overview of the current state of cognitive enhancement compound research, from racetams to newer nootropic peptides.",
    content: [
      "The field of nootropic research — the study of compounds that may affect cognitive function — has evolved dramatically over the past several years. From the classical racetam family to cutting-edge peptide nootropics, researchers now have an unprecedented array of compounds to investigate.",
      "## Defining Nootropics",
      "The term 'nootropic' was coined by Romanian psychologist Corneliu Giurgea in 1972 to describe compounds that enhance learning and memory while having minimal side effects. Today, the research definition has expanded to include any compound studied for its potential effects on cognitive processes, including attention, memory consolidation, executive function, and neuroprotection.",
      "## Classical Nootropics: Racetams",
      "The racetam family remains foundational in nootropics research. Aniracetam and Phenylpiracetam have shown distinct pharmacological profiles, with Aniracetam demonstrating anxiolytic properties in addition to cognitive effects.",
      "## Cholinergic Compounds",
      "Alpha GPC (L-Alpha Glycerylphosphorylcholine) has become a cornerstone of cholinergic nootropics research. As a bioavailable choline source that crosses the blood-brain barrier, it supports acetylcholine synthesis — a neurotransmitter fundamental to memory and learning processes.",
      "## Peptide Nootropics",
      "Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) has shown cognitive effects in animal models at doses substantially lower than classical racetams, suggesting a higher potency profile. Its documented effects on BDNF and NGF make it a key compound in neuroprotection research.",
      "## Mechanisms Under Investigation",
      "Current research is increasingly focused on BDNF modulation, glutamatergic signaling, mitochondrial function in neurons, and neuroinflammation pathways.",
      "## Conclusion",
      "The nootropics research field is more vibrant than ever, with new compounds and mechanisms of action being explored across multiple research institutions worldwide.",
    ],
    pillar: "Nootropics & Cognitive",
    pillarSlug: "nootropics-cognitive",
    author: {
      name: "Dr. Marcus Rivera",
      role: "Lead Pharmacologist",
      avatar: "MR",
    },
    date: "2025-02-15",
    readTime: "10 min read",
    featured: false,
    tags: ["Nootropics", "Cognitive", "Racetams", "Research"],
    relatedSlugs: ["third-party-testing-explained", "peptide-research-beginners-guide"],
  },

  // ─── Research Protocols ───────────────────────────────────────────────────────
  {
    slug: "peptide-research-beginners-guide",
    title: "Peptide Research: A Beginner's Guide to Laboratory Protocols",
    excerpt:
      "Everything new researchers need to know about handling, reconstituting, and studying research peptides in a laboratory setting.",
    content: [
      "Peptide research has grown exponentially over the past decade, with scientists exploring applications ranging from tissue repair to cognitive function. For researchers new to this field, understanding proper handling and experimental protocols is essential for obtaining reliable, reproducible results.",
      "## What Are Research Peptides?",
      "Peptides are short chains of amino acids linked by peptide bonds, typically ranging from 2 to 50 amino acids in length. Research peptides are synthesized specifically for scientific investigation and are not intended for human consumption.",
      "## Reconstitution Protocols",
      "Most research peptides are supplied as lyophilized (freeze-dried) powders for stability. Proper reconstitution is critical for experimental accuracy. The general protocol involves adding bacteriostatic water or sterile saline to the vial, allowing the peptide to dissolve gently without vigorous shaking.",
      "## Storage Requirements",
      "Lyophilized peptides should be stored at -20°C for long-term stability. Once reconstituted, solutions should be stored at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles.",
      "## Quality Verification",
      "Before using any peptide in research, verify its identity and purity through analytical testing. Mass spectrometry confirms molecular weight and amino acid sequence; HPLC analysis provides purity assessment.",
      "## Conclusion",
      "Peptide research offers exciting opportunities for scientific discovery, but success depends on rigorous methodology. By following proper handling protocols and using verified compounds, new researchers can contribute meaningfully to this growing field.",
    ],
    pillar: "Research Protocols",
    pillarSlug: "research-protocols",
    author: {
      name: "Dr. Sarah Chen",
      role: "Research Director",
      avatar: "SC",
    },
    date: "2025-03-05",
    readTime: "10 min read",
    featured: false,
    tags: ["Peptides", "BPC-157", "Laboratory", "Beginners", "Reconstitution"],
    relatedSlugs: ["third-party-testing-explained", "bpc-157-vs-tb-500"],
  },
  {
    slug: "third-party-testing-explained",
    title: "Why Third-Party Testing Matters for Research Compounds",
    excerpt:
      "Understanding the importance of independent analytical verification and what to look for in a Certificate of Authenticity.",
    content: [
      "In the research compound industry, third-party testing is the gold standard for quality assurance. But what exactly does third-party testing entail, and why is it so critical for ensuring the integrity of your research?",
      "## The Problem with Unverified Compounds",
      "Research literature is filled with studies that produced inconsistent results, and a surprising number of these inconsistencies can be traced back to compound quality issues. Without independent verification, researchers cannot be confident that their starting materials are what they claim to be.",
      "## What Third-Party Testing Involves",
      "High-Performance Liquid Chromatography (HPLC) is the primary method for purity assessment. Mass Spectrometry (MS) confirms the molecular identity of the compound by measuring its mass-to-charge ratio.",
      "## Reading a Certificate of Authenticity",
      "A proper COA should include: the compound name and chemical identification, batch number, test date, testing laboratory name and accreditation, analytical method used, purity result, and the signature of the certifying analyst.",
      "## Our Testing Process",
      "Every PureRawz product undergoes testing at accredited independent laboratories. We test for identity, purity, and the absence of contaminants. If a batch fails to meet our quality standards, it is rejected and not offered for sale.",
      "## Conclusion",
      "Third-party testing is the foundation of trustworthy research compound supply. By choosing vendors who provide transparent, verifiable analytical data, researchers protect the integrity of their work.",
    ],
    pillar: "Research Protocols",
    pillarSlug: "research-protocols",
    author: {
      name: "James Whitfield",
      role: "Quality Assurance Director",
      avatar: "JW",
    },
    date: "2025-02-28",
    readTime: "8 min read",
    featured: false,
    tags: ["Quality", "COA", "Testing", "HPLC"],
    relatedSlugs: ["peptide-research-beginners-guide", "research-chemical-regulations-2025"],
  },
  {
    slug: "research-chemical-regulations-2025",
    title: "Navigating Research Chemical Regulations in 2025",
    excerpt:
      "A practical overview of the regulatory landscape for research compounds, including compliance requirements and best practices for responsible sourcing.",
    content: [
      "The regulatory environment surrounding research chemicals continues to evolve, and staying informed about current requirements is essential for researchers, institutions, and suppliers alike.",
      "## Regulatory Framework Overview",
      "Research chemicals occupy a specific regulatory category distinct from pharmaceuticals, supplements, and controlled substances. In the United States, research compounds sold for legitimate scientific purposes are generally regulated under general commercial and safety laws rather than FDA pharmaceutical regulations, provided they are clearly labeled as not for human consumption.",
      "## Labeling and Documentation Requirements",
      "Proper labeling is the foundation of regulatory compliance. Research compounds must be clearly marked with their chemical identity, concentration, batch number, storage requirements, and a prominent statement that the product is for research purposes only.",
      "## Institutional Compliance",
      "Research institutions typically have internal procurement and safety protocols that researchers must follow, including Chemical Hygiene Plans and institutional review requirements.",
      "## PureRawz Compliance Standards",
      "At PureRawz, we maintain rigorous compliance standards including proper labeling, COA documentation, clear 'For Research Purposes Only' messaging, and cooperation with regulatory inquiries.",
      "## Conclusion",
      "Navigating research chemical regulations requires ongoing attention and diligence. By understanding the regulatory framework and choosing compliant vendors, researchers can focus on advancing scientific knowledge.",
    ],
    pillar: "Research Protocols",
    pillarSlug: "research-protocols",
    author: {
      name: "James Whitfield",
      role: "Quality Assurance Director",
      avatar: "JW",
    },
    date: "2025-02-10",
    readTime: "7 min read",
    featured: false,
    tags: ["Regulations", "Compliance", "Industry", "Legal"],
    relatedSlugs: ["third-party-testing-explained", "peptide-research-beginners-guide"],
  },
];

// Dynamically populate counts
blogPillars[0].count = blogPosts.length;
blogPillars.slice(1).forEach((pillar) => {
  pillar.count = blogPosts.filter((p) => p.pillarSlug === pillar.slug).length;
});

export function getPostBySlug(slug: string): BlogPost | undefined {
  return blogPosts.find((p) => p.slug === slug);
}

export function getRelatedPosts(post: BlogPost): BlogPost[] {
  return post.relatedSlugs
    .map((slug) => blogPosts.find((p) => p.slug === slug))
    .filter((p): p is BlogPost => p !== undefined);
}

export function getPostsByPillar(pillarSlug: string): BlogPost[] {
  if (pillarSlug === "all") return blogPosts;
  return blogPosts.filter((p) => p.pillarSlug === pillarSlug);
}

// Keep old export name for backwards compatibility
export const blogCategories = blogPillars;
export const getPostsByCategory = getPostsByPillar;
